0

Are selective contracts with German insurances a smarter reimbursement pathway, Tim Hering?

Within the opportunity of contracting in the German health care market, prices, reimbursement and integrated care paths could be agreed on. However, for some medical devices, especially in the outpatient setting, selective contracts could be the most attractive pathway to… Continue Reading

0

Would AI substitute or (only) support market access managers, Dr. Andree Bates?

Dr Stefan Walzer, market access expert, and his guest Dr. Andree Bates, expert in artificial intelligence (AI), are discussing the future of market access within the health care industry. How could AI support market access planning, submissions and negotiations, especially with… Continue Reading

0

The UK market access has always been complex, now even more than before, Graham Foxon and Paul Craddy?

The UK has always been on the forefront of market access with its unique pathways within England, but especially also considering Wales, Ireland and Scotland as well. Furthermore, since the Brexit there were new innovation paths introduced. The core question remains, how… Continue Reading

0

Switzerland is strong in many aspects, so also in its health care system, Dr. Peter Indra?

The Swiss healthcare system is rather complex but at the same time quite effective. High expenditures into health care corresponds with high life expectancy. However, what are the core processes in Switzerland with regards to health care delivery? What is the… Continue Reading